Author

Noa Rivlin

Observed names: N Rivlin, N. Rivlin

Observed institutions: Johns Hopkins University, Tel Aviv University, Johns Hopkins Medicine, Weizmann Institute of Science

OpenAlex ID: A5001776231

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

2011 · N. Rivlin, R. Brosh, et al. · Genes & Cancer · 1,034

PDF

p53 is balancing development, differentiation and de-differentiation to assure cancer prevention

2010 · A. Molchadsky, N. Rivlin, et al. · Carcinogenesis · 156

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

2010 · Rachel Sarig, Noa Rivlin, et al. · The Journal of Experimental Medicine · 154

PDF

p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity

2013 · A Molchadsky, O Ezra, et al. · Cell Death and Differentiation · 113

PDF

p53, a novel regulator of lipid metabolism pathways

2011 · Ido Goldstein, Osnat Ezra, et al. · Journal of Hepatology · 102

p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways

2010 · Yosef Buganim, Hilla Solomon, et al. · Cancer Research · 77

Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53

2012 · Ido Goldstein, Noa Rivlin, et al. · Carcinogenesis · 65

p53 orchestrates between normal differentiation and cancer

2014 · Noa Rivlin, Gabriela Koifman, et al. · Seminars in Cancer Biology · 54

p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition

2012 · R Brosh, Y Assia-Alroy, et al. · Cell Death and Differentiation · 53

PDF

Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation

2014 · Noa Rivlin, Shir Katz, et al. · Proceedings of the National Academy of Sciences · 52

PDF

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele

2014 · Y Shetzer, S Kagan, et al. · Cell Death and Differentiation · 41

PDF

p53, a novel regulator of lipid metabolism pathways

2012 · Ido Goldstein, Osnat Ezra, et al. · BMC Proceedings · 36

PDF

Thymospheres Are Formed by Mesenchymal Cells with the Potential to Generate Adipocytes, but Not Epithelial Cells

2017 · Julie M. Sheridan, Ashleigh Keown, et al. · Cell Reports · 24

p53 in liver pathologies—taking the good with the bad

2014 · Meital Charni, Noa Rivlin, et al. · Journal of Molecular Medicine · 24

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

2010 · Rachel Sarig, Noa Rivlin, et al. · The Journal of Cell Biology · 17

P651: Real-world Effectiveness of Venetoclax-based Regimens in Patients With Chronic Lymphocytic Leukemia in Israel: Update From the Multicenter Prospective Reveal Study

2023 · Yair Herishanu, Neta Goldschmidt, et al. · HemaSphere · 2

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel

2023 · Naama Yekutiel, Gabriel Chodick, et al. · HemaSphere · 1

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

2022 · Chezi Ganzel, Yakir Moshe, et al. · Blood · 1

Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies

2023 · Irit Avivi, Naama Yekutiel, et al. · Annals of Hematology

Supplementary Figure Legends 1-13 from p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways